Abstract
Executive Summary
"Analytical Tool - Targeted Therapeutics: Melanoma" offers a unique tool for
analyzing the vast amount of strategic possibilities that have emerged in
melanoma R&D and business development. It is at the same time a map of the
research and development, a history of the achievements up to date, and a
guide pointing out the directions of the future. The product as well, lays the
framework of current treatment strategies and their progress. This tool
provides you with an immense amount of information structured and analyzed to
assist you in your work. It is designed to assist you in finding right
partners, optimizing your licensing deals, wisely choosing which projects give
you the best competitive advantage, and assuring you that your decisions have
been based on the most accurate, validated and precise facts available.
Included in this advantageous package are two products already appreciated by
many of our customers - Targeted Therapeutics: Melanoma and Melanoma Drug
Pipeline Update 2007*.
The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active in melanoma R&D
- Information on key industry related melanoma projects
- Data from most important clinical trials
- Information on early developmental stage projects
- Possibility of performing advanced searches suited to your individual needs
This Tool will Assist You in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of melanoma
therapeutics
- Identifying emerging melanoma cancer products & key areas of
pharmaceutical R&D
View Cart
